![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: KIAA0100 |
Gene summary for KIAA0100 |
![]() |
Gene information | Species | Human | Gene symbol | KIAA0100 | Gene ID | 9703 |
Gene name | KIAA0100 | |
Gene Alias | BCOX | |
Cytomap | 17q11.2 | |
Gene Type | protein-coding | GO ID | GO:0005575 | UniProtAcc | Q14667 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
9703 | KIAA0100 | LZE7T | Human | Esophagus | ESCC | 1.33e-05 | 2.82e-01 | 0.0667 |
9703 | KIAA0100 | LZE21D1 | Human | Esophagus | HGIN | 2.21e-03 | 2.10e-01 | 0.0632 |
9703 | KIAA0100 | LZE22T | Human | Esophagus | ESCC | 2.37e-02 | 2.83e-01 | 0.068 |
9703 | KIAA0100 | LZE24T | Human | Esophagus | ESCC | 4.99e-12 | 3.02e-01 | 0.0596 |
9703 | KIAA0100 | LZE21T | Human | Esophagus | ESCC | 2.26e-02 | 2.69e-01 | 0.0655 |
9703 | KIAA0100 | P1T-E | Human | Esophagus | ESCC | 1.11e-12 | 3.62e-01 | 0.0875 |
9703 | KIAA0100 | P2T-E | Human | Esophagus | ESCC | 1.08e-17 | 2.90e-01 | 0.1177 |
9703 | KIAA0100 | P4T-E | Human | Esophagus | ESCC | 8.72e-19 | 3.79e-01 | 0.1323 |
9703 | KIAA0100 | P5T-E | Human | Esophagus | ESCC | 8.33e-11 | 2.00e-01 | 0.1327 |
9703 | KIAA0100 | P8T-E | Human | Esophagus | ESCC | 9.20e-17 | 3.18e-01 | 0.0889 |
9703 | KIAA0100 | P9T-E | Human | Esophagus | ESCC | 3.63e-12 | 1.69e-01 | 0.1131 |
9703 | KIAA0100 | P10T-E | Human | Esophagus | ESCC | 1.05e-30 | 5.93e-01 | 0.116 |
9703 | KIAA0100 | P11T-E | Human | Esophagus | ESCC | 2.46e-08 | 3.23e-01 | 0.1426 |
9703 | KIAA0100 | P12T-E | Human | Esophagus | ESCC | 1.60e-12 | 2.11e-01 | 0.1122 |
9703 | KIAA0100 | P15T-E | Human | Esophagus | ESCC | 1.11e-09 | 2.47e-01 | 0.1149 |
9703 | KIAA0100 | P16T-E | Human | Esophagus | ESCC | 1.40e-14 | 2.28e-01 | 0.1153 |
9703 | KIAA0100 | P17T-E | Human | Esophagus | ESCC | 1.15e-10 | 3.34e-01 | 0.1278 |
9703 | KIAA0100 | P19T-E | Human | Esophagus | ESCC | 4.18e-06 | 3.23e-01 | 0.1662 |
9703 | KIAA0100 | P20T-E | Human | Esophagus | ESCC | 3.83e-13 | 2.21e-01 | 0.1124 |
9703 | KIAA0100 | P21T-E | Human | Esophagus | ESCC | 4.04e-16 | 4.41e-01 | 0.1617 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
KIAA0100 | deletion | Frame_Shift_Del | c.1228delN | p.Arg410GlufsTer56 | p.R410Efs*56 | Q14667 | protein_coding | TCGA-AX-A2HD-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | |||
KIAA0100 | deletion | Frame_Shift_Del | novel | c.2018delN | p.Pro673GlnfsTer20 | p.P673Qfs*20 | Q14667 | protein_coding | TCGA-B5-A0K2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Hormone Therapy | megace | SD | ||
KIAA0100 | insertion | Frame_Shift_Ins | novel | c.4744_4745insGGTT | p.Asn1582ArgfsTer37 | p.N1582Rfs*37 | Q14667 | protein_coding | TCGA-BG-A0MQ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
KIAA0100 | insertion | Nonsense_Mutation | novel | c.4742_4743insAAGCTAGTAACAG | p.Asn1582SerfsTer2 | p.N1582Sfs*2 | Q14667 | protein_coding | TCGA-BG-A0MQ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
KIAA0100 | deletion | Frame_Shift_Del | c.1228delN | p.Arg410GlufsTer56 | p.R410Efs*56 | Q14667 | protein_coding | TCGA-BG-A220-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |||
KIAA0100 | insertion | Frame_Shift_Ins | novel | c.151_152insT | p.Trp51LeufsTer8 | p.W51Lfs*8 | Q14667 | protein_coding | TCGA-DF-A2KN-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD | ||
KIAA0100 | deletion | Frame_Shift_Del | c.151delN | p.Trp51GlyfsTer77 | p.W51Gfs*77 | Q14667 | protein_coding | TCGA-E6-A2P9-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |||
KIAA0100 | deletion | Frame_Shift_Del | c.151delN | p.Trp51GlyfsTer77 | p.W51Gfs*77 | Q14667 | protein_coding | TCGA-EO-A3AU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |||
KIAA0100 | SNV | Missense_Mutation | novel | c.1619N>C | p.Gln540Pro | p.Q540P | Q14667 | protein_coding | tolerated(0.13) | benign(0.209) | TCGA-CC-A8HV-01 | Liver | liver hepatocellular carcinoma | Female | <65 | I/II | Targeted Molecular therapy | sorafenib | PD |
KIAA0100 | SNV | Missense_Mutation | c.2689N>G | p.Met897Val | p.M897V | Q14667 | protein_coding | deleterious(0.01) | possibly_damaging(0.878) | TCGA-DD-A3A1-01 | Liver | liver hepatocellular carcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |